Holen Sie sich die Stockscreener-App
9.06
2.49%
0.22
Handel nachbörslich:
9.01
-0.05
-0.55%
Schlusskurs vom Vortag:
$8.84
Offen:
$8.91
24-Stunden-Volumen:
329.08K
Relative Volume:
0.52
Marktkapitalisierung:
$368.14M
Einnahmen:
$324.01M
Nettoeinkommen (Verlust:
$-192.37M
KGV:
-1.8954
EPS:
-4.78
Netto-Cashflow:
$-23.46M
1W Leistung:
+7.86%
1M Leistung:
-2.79%
6M Leistung:
-13.96%
1J Leistung:
+20.32%
1-Tages-Spanne:
$8.84
$9.18
1-Wochen-Bereich:
$8.36
$9.18
52-Wochen-Spanne:
$5.83
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Vergleichen Sie ANGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
9.06 | 343.36M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Eingeleitet | Lake Street | Buy |
| 2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
| 2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Eingeleitet | Barclays | Equal Weight |
| 2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
| 2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
Is AngioDynamics Inc. building a consolidation base2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Visualizing AngioDynamics Inc. stock with heatmapsInsider Buying & Real-Time Market Trend Scan - Newser
Heatmap analysis for AngioDynamics Inc. and competitors [Earnings Recap Report]Smart Money Movement Tracker - Newser
Can AngioDynamics Inc. rally from current levels [2025 Stock Rankings]Safe Capital Allocation Plans - Newser
Using fundamentals and technicals on AngioDynamics Inc.Predictive Screener for Daily Trade Watch - Newser
Regression analysis insights on AngioDynamics Inc. performanceSafe Entry Strategy with High Win Rate - Newser
Real time alert setup for AngioDynamics Inc. performanceFree Community Shared Smart Money Signals - Newser
Leading vs lagging indicators on AngioDynamics Inc. performanceFree Trade Timing Strategy With Technical Data - Newser
How to recover losses in AngioDynamics Inc. stockDay Trading Setup and Momentum Analysis - Newser
AngioDynamics Inc.’s volatility index tracking explainedNear-Term Market Opportunity Forecast Sheet - Newser
How AngioDynamics Inc. stock performs during market volatilityFree Investment Plan With Growth Optimization - Newser
Can AngioDynamics Inc. rally from current levelsTrade Safety Report with Pattern Insights - Newser
AngioDynamics Inc. stock retracement – recovery analysisFree Stock Portfolio Allocation Guidance - Newser
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Bought by Mackenzie Financial Corp - Defense World
Exit strategy if you’re trapped in AngioDynamics Inc.Free Stock Selection With High Accuracy - Newser
Why AngioDynamics Inc. stock attracts strong analyst attentionDownside Risk Evaluation and Stock Analysis - Newser
Using economic indicators to assess AngioDynamics Inc. potentialProfitable Trading Blueprint with Entry Zones - Newser
Is AngioDynamics Inc. forming a bottoming baseShort-Term Upside Breakout Forecast System - Newser
What makes AngioDynamics Inc. stock price move sharplyCapitalize on market trends early - Jammu Links News
Building trade automation scripts for AngioDynamics Inc.Watchlist Summary for Active Day Traders - Newser
How does AngioDynamics Inc. compare to its industry peersAchieve breakthrough results with expert guidance - Jammu Links News
Is AngioDynamics Inc. a growth stock or a value stockUnlock steady growth with low-risk stocks - Jammu Links News
Is AngioDynamics Inc. stock overvalued or undervaluedMaximize your portfolio’s growth with expert tips - Jammu Links News
Why is AngioDynamics Inc. stock attracting strong analyst attentionInvest confidently with daily market forecasts - Jammu Links News
GSA Capital Partners LLP Takes Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
What are analysts’ price targets for AngioDynamics Inc. in the next 12 monthsHigh-velocity gains - Jammu Links News
Phocas Financial Corp. Takes Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Comparing AngioDynamics Inc. in custom built stock radarsVolume Based Swing Signal Prediction Map - Newser
22,671 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Bought by Y Intercept Hong Kong Ltd - Defense World
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):